Opiant Pharmaceuticals Inc. (OPNT)
$20.65
$0.00 (0.00%)As on 02-Mar-2023 09:30EDT
Market cap
$109 Mln
Revenue (TTM)
$18 Mln
P/E Ratio
--
P/B Ratio
5.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-34 Mln
-
ROE
-1.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-2.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
5,268,680
10 Years Aggregate
CFO
$1.56 Mln
EBITDA
$-49.44 Mln
Net Profit
$-54.06 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Opiant Pharmaceuticals (OPNT)
| 1.8 | 3.1 | 2.3 | -28.8 | 20.7 | -0.1 | 15.2 |
|
BSE Sensex*
| -9.3 | 2.0 | 0.1 | -5.7 | 6.6 | 8.0 | 11.2 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Opiant Pharmaceuticals (OPNT)
| -39.7 | 318.8 | -44.2 | -0.3 | -36.9 | 309.4 | -43.0 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Opiant Pharmaceuticals (OPNT)
|
20.7 | 108.8 | 17.7 | -33.1 | -176.6 | -110.7 | -- | 5.1 |
| 877.7 | 55,840.5 | 6,583.9 | 2,003.3 | 14.7 | 29.9 | 39.7 | 7.6 | |
| 15.5 | 1,030.7 | 0.0 | -167.9 | -- | -128.7 | -- | 5.0 | |
| 25.3 | 15,397.5 | 3,900.9 | 821.0 | 23.5 | 14.4 | 19.1 | 2.7 | |
| 10.3 | 1,884.6 | 550.0 | 458.1 | -3.3 | 45.9 | 4.1 | 1.5 | |
| 3.6 | 804.5 | 4.5 | -340.2 | -518.6 | 501.4 | -- | 2.1 | |
| 14.4 | 1,800.9 | 17.2 | -102.1 | -363.1 | -19 | -- | 3.1 | |
| 12.9 | 904.4 | 369.4 | 12.3 | 7.5 | 5 | 67.4 | 3.4 | |
| 3.2 | 501.2 | 4.0 | -198.4 | -4,917.6 | -166.3 | -- | 6.6 | |
| 18.2 | 1,917.9 | 453.3 | -178.1 | -38.4 | -25.1 | -- | 2.9 |
Shareholding Pattern
View DetailsAbout Opiant Pharmaceuticals (OPNT)
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes... medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California. Read more
-
Pres, CEO & Director
Dr. Roger Crystal M.D.
-
Pres, CEO & Director
Dr. Roger Crystal M.D.
-
Headquarters
Santa Monica, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Opiant Pharmaceuticals (OPNT)
What is the current share price of Opiant Pharmaceuticals Inc (OPNT) Today?
The share price of Opiant Pharmaceuticals Inc (OPNT) is $20.65 (NASDAQ) as of 02-Mar-2023 09:30 EDT. Opiant Pharmaceuticals Inc (OPNT) has given a return of 20.68% in the last 3 years.
What is the current PB & PE ratio of Opiant Pharmaceuticals Inc (OPNT)?
Since, TTM earnings of Opiant Pharmaceuticals Inc (OPNT) is negative, P/E ratio is not available.
The P/B ratio of Opiant Pharmaceuticals Inc (OPNT) is 5.09 times as on 02-Mar-2023, a 3 premium to its peers’ median range of 4.96 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of Opiant Pharmaceuticals Inc (OPNT)?
The 52-week high and low of Opiant Pharmaceuticals Inc (OPNT) are Rs -- and Rs -- as of 21-Jun-2026.
What is the market cap of Opiant Pharmaceuticals Inc (OPNT)?
Opiant Pharmaceuticals Inc (OPNT) has a market capitalisation of $ 109 Mln as on 02-Mar-2023. As per SEBI classification, it is a company.
Should I invest in Opiant Pharmaceuticals Inc (OPNT)?
Before investing in Opiant Pharmaceuticals Inc (OPNT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.